Basic human research study of novel glaucoma endpoints and identification of optimal patient populations for neuroprotection trials
Clinical Trial Grant
Administered By
Ophthalmology, Glaucoma
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
June 10, 2020
End Date
August 22, 2025
Administered By
Ophthalmology, Glaucoma
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
June 10, 2020
End Date
August 22, 2025